Skin News and Research

RSS

New treatment for Tourette Syndrome, patients experience significant resolution of symptoms following brain surgery

A neurosurgical team at University Hospitals of Cleveland (UHC) has, for the first time in North America, applied a new surgical approach to the treatment of Tourette syndrome, resulting in the immediate and nearly complete resolution of symptoms for the patient, who has suffered from this neurologic disorder since he was a child.

1 Apr 2004

Gene of immune system linked to severe adverse drug reaction called Stevens-Johnson syndrome (SJS)

In a study of Han Chinese patients, researchers have for the first time directly linked a gene of the immune system to a severe adverse drug reaction called Stevens-Johnson syndrome (SJS), according to a Duke University Medical Center medical geneticist and collaborators in Taiwan.

1 Apr 2004

Research shows no association between whooping cough vaccine and asthma

Parents who may be concerned by a scare over the side effects of the whooping cough vaccine will be reassured by a new study involving thousands of children. The Department of Health advice that babies should be vaccinated against whooping cough (pertussis) at the age of two, three and four months has been questioned by some scientists who have suggested a link with asthma and allergies.

1 Apr 2004

Lack of iodine prompts new Australian study

A fear that Australians could be suffering serious ill effects from lack of iodine in their diets has prompted a new study of New South Wales, Riverina residents by Charles Sturt University’s (CSU) School of Biomedical Sciences.

30 Mar 2004

A peptide called magainin, found in the skin of the African clawed frog, holds the secret to creating bacteria-killing surfaces

A peptide called magainin, first found in the skin of the African clawed frog, holds the secret to creating bacteria-killing surfaces, according to researchers at the University of Pennsylvania. The Penn scientists have taken a joint experimental-computational approach to mimicking magainin.

30 Mar 2004

75% of young Britains still ignoring skin cancer warnings

Almost three quarters of Britain's young men and women are boosting their risk of potentially fatal skin cancer in their search for a suntan. A specially commissioned survey for Cancer Research UK today reveals that 70 per cent of 16 to 24 year olds still want a tan on holiday despite warnings of over exposure to the sun.

30 Mar 2004

Novel vaccine technology to suppress the growth of certain tumors

MedImmune, Inc. and Cerus Corporation have announced preclinical results demonstrating the effectiveness of a novel therapeutic vaccine technology in suppressing the growth of certain tumors.

From Baxter International Inc. 29 Mar 2004

Researchers have successfully grafted human breast tissue into the mammary glands of mice

The last few years have witnessed critical advances in breast cancer therapies. Still, the disease afflicts one in eight American women, and scientists have yet to develop a living model with which they can study the intricacies of human breast-tumor behavior.

26 Mar 2004

A common antibiotic used to treat arthritis and acne shows promise for limiting the severity of spinal cord and brain injuries

When a fall, car crash, bullet, or knife crushes or cuts a spinal cord, the injury does not stop there. Rather, tissues continue to discharge toxic chemicals for hours, even days and weeks. These chemicals kill and disable nerve cells some distance away from the core injury, compounding the damage and making rehabilitation more difficult or impossible.

26 Mar 2004

Super glue and vascular graft surgery

Got a broken teacup, an art project, or a leaky blood vessel? “Super glue” it. Surgeons at Baylor College of Medicine in Houston are studying whether a liquid sealant, similar to common household “super glue,” forms a tight seal around blood vessels used in vascular graft surgery.

25 Mar 2004

Thyroid disorders are often misdiagnosed

Thyroid disorders are among the most common medical conditions. However, because their symptoms often appear gradually, the condition is often misdiagnosed, according to Dr. Nila Vora, a board-certified endocrinologist at the Loyola Primary Care Center in Darien.

25 Mar 2004

EU gives 32 million Euro for vaccines to stop tuberculosis

The European Commission today launched the largest-ever collaborative tuberculosis (TB) initiative for World TB-day, March 24. Fifty-two research teams from academia and industry from 15 European and African countries are joining forces with the European Commission to help eradicate TB. Globally, TB kills 2 million people a year, with one-third of the world's population currently infected with the bacillus, Mycobacterium tuberculosis (Mtb). While most cases and deaths occur in developing countries, resistant Mtb strains are mainly found among the poorest people in developed countries, as incomplete treatment increases drug resistance. The European Union is confronting the re-emerging threat of TB by investing €32 million in two overlapping research projects. This cash will be used in an accelerated effort to develop new, effective vaccines to fight TB.

23 Mar 2004

Study shows Kinerase cream aids skin appearance

Valeant Pharmaceuticals announced that it has introduced Kinerase(R) Intensive Eye Cream, based on the successful formula of its Kinerase facial lotion and cream. The new eye cream contains a 25 percent higher concentration of Kinetin, the natural substance in Kinerase products that helps the skin retain moisture and reduces the appearance of fine lines and wrinkles.

22 Mar 2004

Raptiva, 20 percent improvement in an individual's signs and symptoms of arthritis.

Genentech, Inc. and XOMA Ltd. today announced preliminary results of a randomized, placebo-controlled Phase II study with RAPTIVA™ (efalizumab) in 107 patients with psoriatic arthritis. The study did not reach statistical significance at 12 weeks (84 days) for the primary endpoint, ACR 20 response. An ACR 20 response indicates at least a 20 percent improvement in an individual's signs and symptoms of arthritis.

22 Mar 2004

The placebo effect, study suggest pain management is possible

A Columbia professor has uncovered fresh evidence of the existence of the often-debated placebo effect. Even the professor himself, Tor D. Wager, of the Department of Psychology, was surprised by his team's findings. The study showed that the human brain processes pain differently when people believe that they have been given a pain-relieving skin cream. Wager, lead author of the study, defines "placebo" as a treatment that has no direct pharmacological effect and that may influence one's experience and physiology through one's beliefs.

22 Mar 2004

New Treatment for Chronic Head Pain

Dr. Levy pioneered a procedure known as supraorbital nerve stimulation or SOS, in which neurotransmitters are implanted into the forehead to block head pain. Tiny wires are burrowed under the skin until the precise location of pain is marked by a tingling response to electrical charge. The wires are kept in place for a week, and if pain is lessened and the patient is comfortable with the technology, neurotransmitters are surgically implanted under local anesthesia. The patient is able to control pain relief by manually adjusting the level of electrical stimulation through a hand held device.

22 Mar 2004

Asian poison ivy like plant may stop prostate cancer

The croton plant, long known to oriental herbalists and homeopaths as a purgative, has an oil in its seeds that shows promise for the treatment of prostate cancer – the second leading cause of cancer death in men in the United States. The active ingredient in the oil is 12-O-tetradecanoylphorbol-13-acetate, a compound generally known as TPA.

22 Mar 2004

Patch for post-surgical pain

A patch that delivers pain medication through the skin is just as effective and more convenient than medication delivered by an intravenous pump for post-surgical pain, according to a new study.

22 Mar 2004

Skin News and Research

New treatment for Tourette Syndrome, patients experience significant resolution of symptoms following brain surgery

Gene of immune system linked to severe adverse drug reaction called Stevens-Johnson syndrome (SJS)

Research shows no association between whooping cough vaccine and asthma

Lack of iodine prompts new Australian study

A peptide called magainin, found in the skin of the African clawed frog, holds the secret to creating bacteria-killing surfaces

75% of young Britains still ignoring skin cancer warnings

Novel vaccine technology to suppress the growth of certain tumors

Researchers have successfully grafted human breast tissue into the mammary glands of mice

A common antibiotic used to treat arthritis and acne shows promise for limiting the severity of spinal cord and brain injuries

Super glue and vascular graft surgery

Thyroid disorders are often misdiagnosed

EU gives 32 million Euro for vaccines to stop tuberculosis

Study shows Kinerase cream aids skin appearance

Raptiva, 20 percent improvement in an individual's signs and symptoms of arthritis.

The placebo effect, study suggest pain management is possible

New Treatment for Chronic Head Pain

Asian poison ivy like plant may stop prostate cancer

Patch for post-surgical pain

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News